SCHEMBL25978638

SCHEMBL25978638

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4oc5cc(-c6nc(-c7cccc(-c8ccccc8)c7)c7sc8ccccc8c7n6)ccc5c34)cc2)cc1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 1/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
PRKDC P78527 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25978640 1.00 LIMK1 (0.31) LIMK1PIM1PIM3PIM2PRKDC
SCHEMBL26779000 0.97 PRKDC (0.31) LIMK1PRKDC
SCHEMBL25978618 0.97 PRKDC (0.31) LIMK1PRKDC
SCHEMBL25978596 0.96 PRKDC (0.31) LIMK1PRKDC
SCHEMBL25978616 0.96 PRKDC (0.31) LIMK1PRKDC
SCHEMBL25978598 0.94
SCHEMBL25978601 0.94
SCHEMBL25978615 0.92 PRKDC (0.32) PRKDC
SCHEMBL25978612 0.91 PRKDC (0.33) PRKDC
SCHEMBL26415639 0.89 PRKDC (0.35) LIMK1PIM1PIM3PIM2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 LIMK1 528/4885PIM1 1100/4885PIM3 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.